Defense Startup Covenant Exits Stealth With $250M Funding and Long-Range Strike Weapon

Key facts

Covenant formally stepped into the public defense market after operating in secrecy, presenting both its primary hardware system and an established global manufacturing footprint. The company's flagship product, named Anthem, is categorized as a long-range strike weapon designed to provide standoff precision attack capabilities. The unveiling targets a critical requirement highlighted by recent conflicts, where Western militaries and partner nations have faced persistent inventory strains in precision artillery, cruise missiles, and loitering munitions.

According to reporting by Ana-Maria Stanciuc, Covenant backed its product launch with $250 million in total capital raised from private investors. Rather than concentrating resources solely on prototype testing or software simulation before seeking government factory grants, Covenant deployed capital directly into building heavy industrial infrastructure during its stealth period. The result is a tri-regional production strategy consisting of active manufacturing facilities in Texas, Germany, and Israel.

In addition to its capital reserves and operational factories, Covenant announced it has secured $150 million in initial orders. The presence of a nine-figure order backlog at the moment of exit from stealth indicates that defense buyers or sovereign defense ministries evaluated the Anthem platform and committed acquisition funding prior to the company's public debut. This pre-launch customer engagement bypasses traditional multi-year sales cycles typically required for new defense aerospace systems.

Why it matters

The launch of Covenant with $250 million in capital, $150 million in orders, and three international factories signals a structural shift in how private defense hardware ventures compete against established defense primes. Historically, aerospace startups spent years advancing prototypes through government research grants before attempting to secure dedicated manufacturing facilities. By constructing plants in Texas, Germany, and Israel prior to its public emergence, Covenant is attempting to resolve the defense sector's traditional "valley of death"—the prolonged delay between successfully testing a weapon prototype and scaling it into full-rate industrial production.

The geographic selection of Covenant's three manufacturing sites carries direct strategic implications for Allied military supply chains. Standoff strike weapons require resilient, high-capacity manufacturing lines capable of withstanding regional geopolitical shocks, trade bottlenecks, or export delays. Establishing a facility in Texas provides direct access to U.S. Department of Defense acquisition channels, expansive military test ranges, and American defense industrial networks. Operating a factory in Germany locates production inside the European Union and NATO's European pillar, offering localized sourcing for European governments accelerating rearmament efforts without total reliance on U.S. transatlantic shipping. Meanwhile, establishing a footprint in Israel connects the firm to an advanced defense innovation ecosystem experienced in rapid military prototyping and combat feedback loops. This distributed industrial arrangement allows Covenant to market its Anthem system as a domestically produced asset across three major sovereign defense markets, complying with local industrial participation mandates and sovereign defense requirements.

The emergence of venture-backed defense manufacturing firms comes amidst a broader reassessment of Western defense industrial capacity. Over the past several years, modern high-intensity conflicts in Eastern Europe and the Middle East revealed severe limitations in Allied munitions stockpiles. Traditional defense prime contractors—including Lockheed Martin, RTX, General Dynamics, Northrop Grumman, and BAE Systems—have faced operational hurdles in rapidly multiplying production rates for long-range missiles, artillery shells, and precision guidance kits. Decades of peacetime consolidation created lean, centralized supply chains optimized for steady, low-rate procurement rather than rapid surge capacity.

To address these vulnerabilities, venture capital firms and private equity groups have significantly increased investment in dual-use technologies and dedicated defense startups. This influx of capital fostered a generation of venture-backed defense suppliers, such as Anduril Industries, Palantir Technologies, Shield AI, and Epirus. These companies emphasize commercially funded research, agile software iteration, rapid hardware prototyping, and automated factory design over the protracted cost-plus contracting models traditionally favored by government procurement agencies.

In parallel, government defense institutions have restructured their acquisition mechanisms to onboard non-traditional vendors more rapidly. In the United States, the Department of Defense expanded the role of the Defense Innovation Unit and launched the Replicator initiative, a program designed to field thousands of low-cost, autonomous, attrition-tolerant systems across multiple combat domains. In Europe, Germany enacted its historic "Zeitenwende" defense policy overhaul, establishing a €100 billion special defense fund alongside increased annual defense spending to rebuild Bundeswehr weapon inventories and strengthen NATO's eastern posture. Simultaneously, Israel's defense tech sector has maintained a high rate of hardware innovation, integrating artificial intelligence and autonomous capabilities directly into military field operations. Covenant's debut with $250 million in backing and three operational factories represents a continuation of this macro-level convergence, where private capital is leveraged to establish high-rate kinetic weapon manufacturing across multiple Allied jurisdictions simultaneously.

Reaction

Although official military procurement entities have not yet published formal comments regarding Covenant's announcement or the composition of its $150 million order book, industry reactions are expected across several distinct domains. Traditional defense prime contractors are likely to closely monitor Covenant's industrial execution, as the entry of a well-capitalized competitor offering long-range strike weapons threatens legacy monopolies in precision munitions and standoff missile production.

Within the venture capital community, Covenant's pre-launch construction of three international factories sets a high capital benchmark for defense hardware startups, signaling that future funding rounds in the sector may increasingly favor teams capable of delivering immediate industrial capacity alongside hardware designs. On the regulatory front, national export control agencies—including the U.S. Department of State's Directorate of Defense Trade Controls, which administers International Traffic in Arms Regulations, alongside Germany's Federal Office for Economic Affairs and Export Control—will play a key role in governing how Covenant transfers technical data, proprietary components, and software code between its operations in Texas, Germany, and Israel.

What we don't know yet

Despite the details provided upon exiting stealth, several operational and technical facts remain undisclosed in the initial reporting by Ana-Maria Stanciuc. The identities of the private venture capital firms, institutional funds, or strategic investors that supplied the $250 million in capital have not been revealed. Similarly, the specific government entities, foreign militaries, or corporate buyers responsible for the $150 million in advance orders remain unspecified.

On the technical side, Covenant has not released detailed performance specifications for the Anthem weapon system. Critical unconfirmed parameters include its exact maximum operational range, warhead payload options, flight propulsion mechanisms, guidance and navigation architecture (such as resistance to GPS jamming or terminal optical tracking), and per-unit flyaway cost. Furthermore, exact production capacity figures—such as monthly or annual unit throughput for each factory in Texas, Germany, and Israel—have not been detailed, nor has the company disclosed its total current global headcount or the legal structure governing cross-border intellectual property rights across its international subsidiaries.

What to watch

In the coming months, several key developments will indicate Covenant's ability to transition from its stealth debut to sustained defense manufacturing. Observers should look for live-fire flight demonstrations and public target-impact trials of the Anthem platform, which will provide empirical validation of its advertised range, accuracy, and flight stability under operational conditions.

Additional monitoring should focus on formal procurement disclosures from the U.S. Department of Defense, European NATO defense ministries, or the Israel Defense Forces that confirm specific line-item purchases associated with Covenant's $150 million order backlog. Progress at the manufacturing sites in Texas, Germany, and Israel will serve as another major indicator, particularly regarding facility expansions, local hiring milestones, and full-rate production certifications. Finally, regulatory filings concerning cross-border defense trade licenses and potential strategic partnerships or subcontracting agreements with established aerospace suppliers will reveal how effectively Covenant can integrate its distributed supply chain within the broader Western defense industrial base.

This report is based on original reporting by Ana-Maria Stanciuc.